Related Experiment Video
Updated: Apr 13, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
New Targets for Prevention of Schizophrenia: Is It Time for Interventions in the Premorbid Phase?
Larry J Seidman1, Merete Nordentoft2
1Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel Deaconess Medical Center, Department of Psychiatry, Harvard Medical School, Boston, MA; Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital, Boston, MA; lseidman@bidmc.harvard.edu.
Insights
Early intervention for schizophrenia is gaining traction, focusing on developmental vulnerabilities before psychosis onset. This special issue explores interventions targeting the premorbid period, even during pregnancy, addressing ethical considerations.
Area of Science:
- Neuroscience
- Psychiatry
- Developmental Psychology
Background:
- Growing evidence highlights premorbid developmental vulnerabilities to psychosis, particularly schizophrenia.
- Interventions during the clinical high-risk (CHR) phase show promise, but CHR is recognized as a late stage of developmental disruption.
- This necessitates exploring even earlier intervention strategies.
Discussion:
- The Special Theme Issue examines new data on early neurocognitive development.
- It proposes potential psychosocial and psychopharmacological intervention targets during the premorbid period, including during pregnancy.
- Ethical challenges associated with these interventions are also discussed.
Key Insights:
- A paradigm shift towards very early intervention in schizophrenia is emerging.
- Interventions may target neurodevelopmental trajectories years before psychosis onset.
- Balancing potential benefits with ethical considerations is crucial.
Outlook:
- Empirical testing of proposed interventions is required.
- Ethical, safety, stigma, feasibility, efficacy, and tolerability must be rigorously evaluated.
- Understanding the subjective meaning of interventions for individuals is paramount.
Abstract:
A number of influences have converged that make this Special Theme Issue timely: "A New Direction: Considering Developmentally Sensitive Targets for Very Early Intervention in Schizophrenia". These factors include: 1. the substantial knowledge about premorbid developmental vulnerabilities to psychosis, especially regarding schizophrenia; 2. the promising results emerging from interventions during the clinical high-risk (CHR) phase of psychosis and; 3. the recognition that the CHR period is a relatively late phase of developmental derailment. These factors have together led to a perspective that even earlier intervention is warranted. This paper briefly summarizes the articles comprising the Special Theme including new data on early neurocognitive development, proposed potential targets for psychosocial and psychopharmacological interventions during the premorbid period as early as pregnancy, and ethical challenges. These thought experiments must be empirically tested, and the ethical challenges overcome as posed by the various interventions, which range from relatively low risk, supportive, psychosocial to higher risk, experimental, pharmacological interventions. All of the interventions proposed require careful study of ethics, safety, potential stigma, feasibility, efficacy and tolerability, and the meaning to the people involved.
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychosis: Goals of Pharmacotherapy
Schizophrenia
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Psychosis and Antipsychotic Drugs: Overview

